Skip to Content

'
Shalini Dalal, MD

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Palliative Care and Rehabilitation Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Office Address

Education & Training

Degree-Granting Education

1989 Armed Forces Medical College, Pune, India, MBBS, Medicine

Postgraduate Training

2003-2004 Clinical Fellowship, Symptom Control and Palliative Care, The University of Texas MD Anderson Cancer Center, Houston, TX
1994-1997 Clinical Residency, Internal Medicine, Prince George's Hospital Center, Cheverly, MD
1990-1994 Clinical Internship, Medicine, Army Hospital, New Delhi, India
1989 Clinical Internship, Station Health Organization, Pune, India

Board Certifications

4/2010 American Board of Hospice and Palliative Medicine
4/2010 American Board of Internal Medicine

Experience/Service

Academic Appointments

Adjunct Member, The University of Texas Graduate School of Biomedical Sciences, Houston, TX, 5/2010-6/2011
Assistant Professor, Department of Palliative Care and Rehabilitation Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2004-8/2011

Administrative Appointments/Responsibilities

Co-Director - Outpatient Cachexia Clinic, Department of Palliative Care and Rehabilitation Medicine, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006-2011

Other Appointments/Responsibilities

Staff Physician, Veterans Affairs Puget Sound Health Care System, Tacoma, WA, 2001-2003
Staff Physician, Veterans Affairs Medical Center, Fargo, ND, 1998-2001
Physician, Private Practice, Atlanta, GA, 1997-1998

Military or Other Governmental Service

Captain/Medical Officer, India, 1990-1994

Institutional Committee Activities

Vice Chair, Institutional Review Board II, 9/2012-present
Faculty Senator, Faculty Senate, 9/2009-present
Member, Institutional Review Board II, 8/2009-8/2012
Project Leader, Institutional Cancer Pain Management Guidelines, 2008-present
Member, Failure Mode & Effects Analysis (FMEA): Reducing the Risk of Patient Harm with Opiates, 2008-present
Member, Midlevel Schedule II Workgroup, 2008-2012
Member, Pharmacy & Therapeutics Committee, 2008-2010
Member, Clinical Effectiveness Committee, 2007-present
Member, Hospice and Palliative Medicine Intensive Physician Board Review Planning Committee, 2007-2010
Member, Cancer Survivorship Research Committee, 2007-2009
Associate Member, Institutional Review Board II, 2006-7/2009
Member, Advance Directive Project Team, 2006-2007

Honors and Awards

2012 Apple Award, The University of Texas MD Anderson Cancer Center
2010 National Institute of Health Award Merit - PDQ Supportive and Palliative Care Editorial Board, National Cancer Institute, National Institute of Health

Professional Memberships

American College of Physicians
Member, 1/2004-present
American Medical Association
Member, 1/2004-present
American Society of Clinical Oncology
Member, 1/2007-present
European Association for Palliative Care
Member, 1/2007-present
Focus Group on cancer cachexia classification for the European Palliative Care Research Collaborative
Member, 1/2008-present
Harris County Medical Society, Houston, TX
Member, 1/2004-present
Indo-American Cancer Association, Dallas, TX
Lifetime Member, 9/2011-present
Multinational Association of Supportive Care in Cancer
Member, 1/2006-present
National Comprehensive Cancer Network, Fort Washington, PA
Panel Member, 11/2009-present
Public Responsibility in Medicine and Research
Member, 8/2007-present

Selected Publications

Peer-Reviewed Original Research Articles

1. Rhondali W, Burt S, Wittenberg-Lyles E, Bruera E, Dalal S. Medical oncologists' perception of palliative care programs and the impact of name change to supportive care on communication with patients during the referral process. A qualitative study. Palliat Support Care 11(5):1-8, 10/2013. e-Pub 1/10/2013. PMID: 23302500.
2. Yennurajalingam S, Frisbee-Hume S, Palmer JL, Delgado-Guay MO, Bull J, Phan AT, Tannir NM, Litton JK, Reddy A, Hui D, Dalal S, Massie L, Reddy SK, Bruera E. Reduction of cancer-related fatigue with dexamethasone: a double-blind, randomized, placebo-controlled trial in patients with advanced cancer. J Clin Oncol 31(25):3076-82, 9/1/2013. e-Pub 7/29/2013. PMID: 23897970.
3. Dalal S, Tanco KC, Bruera E. State of art of managing pain in patients with cancer. Cancer J 19(5):379-89, Sep-Oct, 9/2013. PMID: 24051610.
4. Rhondali W, Perez-Cruz P, Hui D, Chisholm GB, Dalal S, Baile W, Chittenden E, Bruera E. Patient-physician communication about code status preferences: A randomized controlled trial. Cancer 119(11):2067-73, 6/1/2013. e-Pub 4/5/2013. PMID: 23564395.
5. Bruera E, Hui D, Dalal S, Torres-Vigil I, Trumble J, Roosth J, Krauter S, Strickland C, Unger K, Palmer JL, Allo J, Frisbee-Hume S, Tarleton K. Parenteral hydration in patients with advanced cancer: a multicenter, double-blind, placebo-controlled randomized trial. J Clin Oncol 31(1):111-8, 1/1/2013. e-Pub 11/19/2012. PMCID: PMC3530688.
6. Levy MH, Adolph MD, Back A, Block S, Codada SN, Dalal S, Deshields TL, Dexter E, Dy SM, Knight SJ, Misra S, Ritchie CS, Sauer TM, Smith T, Spiegel D, Sutton L, Taylor RM, Temel J, Thomas J, Tickoo R, Urba SG, Von Roenn JH, Weems JL, Weinstein SM, Freedman-Cass DA, Bergman MA, NCCN (National Comprehensive Cancer Network). Palliative care. J Natl Compr Canc Netw 10(10):1284-309, 10/2012. PMID: 23054879.
7. Dev R, Dalal S, Bruera E. Is there a role for parenteral nutrition or hydration at the end of life? Curr Opin Support Palliat Care 6(3):365-370, 9/2012. PMID: 22801468.
8. Dalal S, Hui D, Nguyen L, Chacko R, Scott C, Roberts L, Bruera E. Achievement of personalized pain goal in cancer patients referred to a supportive care clinic at a comprehensive cancer center. Cancer 118(15):3869-77, 8/1/2012. e-Pub 12/16/2011. PMCID: PMC3310943.
9. Hui D, Arthur J, Dalal S, Bruera E. Quality of the supportive and palliative oncology literature: a focused analysis on randomized controlled trials. Support Care Cancer 20(8):1779-1785, 8/2012. e-Pub 9/21/2011. PMID: 21935717.
10. Dalal S, Hui D, Bidaut L, Lem K, Del Fabbro E, Crane C, Reyes-Gibby CC, Bedi D, Bruera E. Relationships among body mass index, longitudinal body composition alterations, and survival in patients with locally advanced pancreatic cancer receiving chemoradiation: a pilot study. J Pain Symptom Manage 44(2):181-91, 8/2012. e-Pub 6/2012. PMID: 22695045.
11. Hui D, Kilgore K, Fellman B, Urbauer D, Hall S, etal. Development and Cross-Validation of the In-Hospital Mortality Prediction in Advanced Cancer Patients Score: A Preliminary Study. Journal of Palliative Medicine 15(8):902-09, 4/2012.
12. Hui D, Kilgore K, Nguyen L, Hall S, Fajardo J, Cox-Miller TP, Palla SL, Rhondali W, Kang JH, Kim SH, Del Fabbro E, Zhukovsky DS, Reddy S, Elsayem A, Dalal S, Dev R, Walker P, Yennu S, Reddy A, Bruera E. The Accuracy of Probabilistic Versus Temporal Clinician Prediction of Survival for Patients with Advanced Cancer: A Preliminary Report. Oncologist, 11/2011. PMID: 21976316.
13. Del Fabbro E, Hui D, Dalal S, Dev R, Noorhuddin Z, Bruera E. Clinical Outcomes and Contributors to Weight Loss in a Cancer Cachexia Clinic. J Palliat Med 14(9):1004-8, 9/2011. e-Pub 7/27/2011. PMCID: PMC3166181.
14. Dalal S, Hui D, Nguyen LMT, Chacko R and Bruera E. Achievement of personalized pain goal (PPG) in cancer patients referred to a supportive care clinic. Proceedings of American Association of Clinical Oncology, Annual Meeting. Journal of Clinical Oncology 29(15S), 5/2011.
15. Dev R, Hui D, Dalal S, Nooruddin ZI, Yennurajalingam S, Del Fabbro E, Bruera E. Association between serum cortisol and testosterone levels, opioid therapy, and symptom distress in patients with advanced cancer. J Pain Symptom Manage 41(4):788-95, 4/2011. e-Pub 1/28/2011. PMID: 21276699.
16. Del Fabbro E, Dev R, Hui D, Dalal S, Bruera E. Secondary Cachexia in Patients with Advanced Cancer. J Pain Symptom Manage 41(1):233-234, 1/2011.
17. Dalal S, Palla S, Hui D, Nguyen L, Chacko R, Li Z, Fadul N, Scott C, Thornton V, Coldman B, Amin Y, Bruera E. Association Between a Name Change from Palliative to Supportive Care and the Timing of Patient Referrals at a Comprehensive Cancer Center. Oncologist 16(1):105-111, 2011. e-Pub 1/2011. PMID: 21212438.
18. Del Fabbro E, Hui D, Nooruddin Z, Dalal S, Dev R, Freer G, Palmer JL, Bruera E. Association between hypogonadism, inflammatory marker, symptom survival in cancer patients with cachexia: A preliminary report. Cancer, 6/2010.
19. Del Fabbro E, Hui D, Nooruddin ZI, Dalal S, Dev R, Freer G, Roberts L, Palmer JL, Bruera E. Associations Among Hypogonadism, C-Reactive Protein, Symptom Burden, and Survival in Male Cancer Patients with Cachexia: A Preliminary Report. J Pain Symptom Manage 39(6):1016-1024, 6/2010. PMCID: PMC20457506.
20. Mori M, Fadul NA, Bruera E, Dalal S. Hypocalcemia Associated with Strontium-89 Administration in a Patient with Diffuse Bone Metastases from Neuroendocrine Carcinoma. J Pain Symptom Manage 37(5):923-929, 5/2009. PMCID: PMC19041217.
21. Dalal S, Del Fabbro E, Bruera E. Is there a role for hydration at the end of life? Curr Opin Support Palliat Care 3(1):72-78, 3/2009. PMCID: PMC19365165.
22. Fadul NA, El Osta B, Dalal S, Poulter VA, Bruera E. Comparison of Symptom Burden among Patients Referred to Palliative Care with Hematologic Malignancies versus those with Solid Tumors. J Palliat Med 11(3):422-7, 4/2008. PMCID: PMC18363482.
23. Dalal S, Zhukovsky DS. Pathophysiology and management of hot flashes. J Support Oncol 4(7):315-20, 325, Jul-Aug, 7/2006. PMCID: PMC16892692.
24. Dalal S, Del Fabbro E, Bruera E. Symptom control in palliative care-part I: oncology as a paradigmatic example. J Palliat Med 9(2):391-408, 4/2006. PMCID: PMC16629570.
25. Del Fabbro E, Dalal S, Bruera E. Symptom Control in Palliative Care-Part II: Cachexia/Anorexia and Fatigue. J Palliat Med 9(2):409-21, 4/2006. PMCID: PMC16629571.
26. Del Fabbro E, Dalal S, Bruera E. Symptom Control in Palliative Care-Part III: Dyspnea and Delirium. J Palliat Med 9(2):422-36, 4/2006. PMCID: PMC16629572.
27. Dalal S, Zhukovsky DS. Pathophysiology and management of fever. J Support Oncol 4(1):9-16, 1/2006. PMCID: PMC16444847.
28. Dalal S, Bruera E. Dehydration in cancer patients: to treat or not to treat. J Support Oncol 2(6):467-79, 483, Nov-Dec, 11/2004. PMID: 15605914.
29. Del Fabbro E, Nooruddin Z, Hui D, Dalal S, Bruera E. Nutrition Impact Symptoms in Cancer Patients Referred to a Cachexia Clinic at a Comprehensive Cancer Center. J Palliat Med. Submitted.

Invited Articles

1. Dalal S, Bruera E. Assessing cancer pain. Curr Pain Headache Rep 16(4):314-24, 8/2012. PMID: 22585314.
2. Dalal S. Book Review: Ensuring Delivery of the Highest Quality of Care for Dying Patients. J Pain Symptom Manage 42(6):967-968, 12/2011.
3. Dalal S, Bruera E. Assessment and management of pain in the terminally ill. Prim Care Clinic Office Pract 38(2):195-223, 6/2011. PMCID: PMC21628035.
4. Dalal S, Bruera E. Global Perspectives in Cancer Pain--progress and ongoing issues in the United States. Pain Res Manag 14(5):363-364, Sep-Oct, 9/2009. PMID: 19946974.

Abstracts

1. Dalal S, Hui D, Nguyen L, Chacko R, Bruera E. Assessment of personalized pain goal (PPG) in cancer patients referred to the Supportive Care Clinic for pain management. 7th World Research Congress of the European Association for Palliative Care (#A-422-0002-00738), 2012.
2. Dalal S, Hui D, Ngyuen L, Chacko R, Bruera. Achievement of personalized pain goal (PPG) in cancer patients referred to the supportive care clinic at a comprehensive cancer center. Proceedings of Multinational Association of Supportive Care in Cancer (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 19(Suppl 2) (#S279), 6/2011.
3. Hui D, Kilgore KL, Nguyen LMT, Hall S, Fajardo J, Cox-Miller T, Urbauer D. Fellman B, Rhondali W, Kang JH, Kim H, Del Fabbro E, Zhukovsky DS, Reddy SK, Elsayem AF, Dalal S, Walker P, Dev R, Yennurajalingam S, Bruera E. Predictors of in-hospital mortality in advanced cancer patients submitted to an acute palliative care unit (APCU): A prospective study Proceedings of Multinational Association of Supportive Care in Cancer (MASCC), Annual Meeting. Support Care Cancer 19(Supplement 2):S221 (#461), 6/2011. PMID: 21656340.
4. Hui D, Kilgore K, Nguyen L, Hall S, Fajardo J, Cox-Miller T, Rhondali W, Kim SH, Kang, JH, Palla S, Del Fabbro E, Zhukovsky DS, Reddy S. Elsayem A, Dalal S, Walker P, Dev R, Yennu S, Reddy A, Bruera E. The accuracy of clinical prediction of survival (CPS) for advanced cancer patients: The role of profession and probability questionProceedings of Multinational Association of Supportive Care in Cancer (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 19(Suppl 2) (#S215), 6/2011.
5. Dev R, Del Fabbro E, Palla S, Hui D, Guitierrez N, Dalal S, Yennurajalingam S. Bruera E. Vitamin D Deficiency and Endogrin Abnormalities in Advanced Cancer Patients Proceedings of Multinational Association of Supportive Care in Cancer (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 19(Suppl 2) (#S136), 6/2011.
6. Dalal S, Palla S, Chacko R, Nguyen L, Fadul N, Bruera E. Does A Name Change from "Palliative" to "Supportive" Care Have Any Impact on Patient Referrals? A Retrospective Data Review. Proceedings of Multinational Association of Supportive Care in Cancer (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 18(Supplement 3):S67-S220 (#14-122), 6/2010.
7. Dalal S, Palla SL, Chacko R, Nguyen L, Fadul N, Li Z, Bruera E. Impact of change in service name from "Palliative" to "Supportive" care on patient referral at a comprehensive cancer center. Proceedings of American Society of Clinical Oncology (ASC0), Annual Meeting. Journal of Clinical Oncology 28(15S) (#9052), 6/2010.
8. Del Fabbro D, Dalal S, Bruera E. A randomized placebo-controlled trial of melatonin for poor appetite in advanced cancer patients. Proceedings of American Association of Clinical Oncology, Annual Meeting. Journal of Clinical Oncology 28(15S) (#TPS319), 2010.
9. Nooruddin Z, Hui D, Dalal S, Bruera E, Del Fabbro E. Findings and Interventions in Cancer Patients referred to a Cachexia Clinic. Proceedings of Multinational Association in Supportive Care (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 17 (#03-022), 6/2009.
10. Dalal S, Hui D, Noorruddin Z, Del Fabbro E, Freer G, Bruera E. Impact of a Multidisciplinary Cachexia Clinic at a Tertiary Cancer Hospital on Patient Related Outcomes. Proceedings of Multinational Association in Supportive Care (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 17 (#13-117), 6/2009.
11. Del Fabbro E, Hui D, Nooruddin ZR, Dalal S, Dev R, Freer G, Palmer L, Bruera E. Association between inflammatory markers, symptom burden, hypogonadism and survival in cancer patients with cachexia. Proceedings of American Society Clinical Oncology (ASCO), Annual Meeting. Journal of Clinical Oncology 27(15S) (#9594), 2009.
12. Del Fabbro E, Hui D, Nooruddin Z, Dalal S, Palmer L, Bruera E. Association Between Inflammatory Markers, Symptom Burden, Hypogonadism and Survival In Cancer Patients with Cachexia. Proceedings of Multinational Association of Supportive Care in Cancer (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 17:857-1039 (#18-188), 2009.
13. Dalal S, Hui D, Bidaut L, Del Fabbro E, Reyes-Gibby C, Deepak B, Lem K, Hess K, Crane C, Bruera E. Differential Impact of Changes in Muscle and Adipose Tissue on Survival of Men and Women with Locally Advanced Pancreatic Cancer (LAPC) receiving Chemoradiation (CRT). Proceedings of American Society Clinical Oncology (ASCO), Annual Meeting. Journal of Clinical Oncology 26(May 20 suppl) (#9640), 2008.
14. Dalal S, Hui D, Bidaut L, Hess K, Crane C, Bruera E. Gender based differences in the relationship between body composition alterations, as measured by computerized tomography (CT) imaging, and survival, in locally advanced pancreatic cancer (LAPC) receiving chemoradiation. Proceedings of Multinational Association of Supportive Care in Cancer (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 16 (#02-022), 2008.
15. Braiteh F, Dalal S, Khuwaja A, David H, Bruera E, Kuzrock R. Phase I pilot study of the safety and tolerability of olanzapine (OZA) for the treatment of cachexia in patients with advanced cancer. Proceedings of American Society Clinical Oncology (ASCO), Annual Meeting. Journal of Clinical Oncology 26(I5S) (#20529), 2008.
16. Dalal S, Del Fabbro E, Freer G, Bruera E. Relationship between inflammation and symptom distress in cachectic cancer patients assessed at a cachexia clinic in a comprehensive cancer center. Proceedings of Multinational Association in Supportive Care (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 16 (#02-023), 2008.
17. Dalal S, Del Fabbro E, Yennurajalingam S, Palmer S, Bruera E. Cachexia syndrome symptom cluster in patients referred to a specialized cachexia clinic in a comprehensive cancer center. Proceedings of Multinational Association in Supportive Care (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 15:774-775 (#P-196), 2007.
18. Del Fabbro E, Dalal S, Delgado M, Freer G, Bruera E. Secondary vs. primary cachexia in patients with advanced cancer. Proceedings of American Society Clinical Oncology (ASCO) Annual Meeting. Journal of Clinical Oncology. Journal of Clinical Oncology 25(18S) (#9128), 2007.
19. Fadul N, El Osta B, Dalal S, Elsayem A and Bruera E. Symptom burden severity in patients with advanced solid vs. hematological malignancies. Proceedings of Multinational Association in Supportive Care (MASCC), Annual Meeting. Journal of Supportive Care in Cancer 15 (#P-231), 2007.
20. Reddy S, Dalal S, Swafford J, El Osta B, Pei B, Palmer J, Bruera E. The effect of methadone on the QTc interval in advanced cancer patients. Proceedings of American Society Clinical Oncology (ASCO), Annual Meeting. Journal of Clinical Oncology 25(18S) (#9064), 2007.
21. Dalal S, Pimentel LE, Wygant C. Multidimensional Assessment Of Cancer Pain. Moving Beyond The Basics. 2013 American Academy of Hospice and Palliative Medicine & Hospice and Palliative Nurses Association Annual Assembly (#255). Submitted.

Book Chapters

1. Dalal S, Bruera E. Principles of Hospice and Palliative Care. In: Oncology for the Primary Care Clinician. Ed(s) Rose M, Devita V, Lawrence T, Rosenberg S. Lippincott Williams & Wilkins: Philadelphia. In Press.
2. Dalal S, Bruera E. Methadone and Buprenorphine Prescribing in the Palliative Care Population. In: Handbook of Methadone Prescribing and Buprenorphine Therapy. Ed(s) Cruciani R, Knotkova H. Springer: New York, 241-261, e-Book 2013. ISBN: 978-1-4614-6973-5.
3. Dalal S. Chapter 10: Chronic Nausea and Vomiting. In: Oxford American Handbook of Hospice and Palliative Medicine, 1. Ed(s) Yennurajalingam S, Bruera E. Oxford University Press: New York, 127-138, 2011. ISBN: ISBN13:9780195380156.
4. Dalal S, Bruera E. Chapter 15: Cancer Anorexia and Cachexia. In: Supportive Oncology, 1st Edition, 1st. Ed(s) M Davis, P Feyer, P Ortner, C Zimmerman. Elsevier Saunders: Philadelphia, 151-160, 2011. ISBN: 978-1-4377-1015-1.
5. Dalal S. Chapter 7: Dehydration in Cancer Patients. In: Oxford American Handbook of Hospice and Palliative Medicine, 1. Ed(s) Yennurajalingam S, Bruera E. Oxford University Press: New York, 97-103, 2011. ISBN: ISBN13:9780195380156.
6. Dalal S. Nutritional Management in Recurrent, Advanced or Metastatic Cancer. In: Nutrition and the Cancer Patient, 1st. Ed(s) E Del Fabbro, V Baracos, W Denmark-Wahnefried, T Bowling, J Hopkinson, E Bruera. Oxford University Press: New York, 435-444, 2010. ISBN: 9780199550197.
7. Dalal S, Palat G, Bruera E. Chronic Nausea and Vomiting. In: Principles and Practice of Palliative Care and Supporting Oncology, 3rd. Ed(s) A Berger , J Shuster, J Von Roenn. Lippincott Williams & Wilkins: Philadelphia PA, 151-162, 2007.
8. Dalal S, Palat G, Bruera E. Management of Dyspnea. In: Principles and Practice of Palliative Care and Supportive Oncology, 3rd. Ed(s) A Berger, J Shuster, J von Roenn. Lippincott Williams & Wilkins: Philadelaphia, PA, 277-290, 2007.
9. Dalal S, Zhukovsky DS, Bruera E. Fever and Hot Flashes. In: Palliative Medicine. Ed(s) Bruera E, Higginson I, Ripamonti C, von Gunten C. Edward Arnold Ltd. London, 2006.
10. Dalal S, Bruera E. Pathophysiology of chemotherapy induced nausea and emesis: In Chemotherapy Induced Nausea and Emesis. In: Prevention of Chemotherapy Induced Nausea and Vomiting. Ed(s) A. Berger. CMP Healthcare Media: New York, 2004.
11. Dalal S. Pneumonia. In: Internal Medicine Issues in Palliative Care. Submitted.
12. Dalal S. UTI. In: Internal Medicine Issues in Palliative Care. Submitted.

Manuals, Teaching Aids, Other Teaching Publications

1. Dalal S. Cachexia: M.D. Anderson's Guide to Palliative Care for Nurses, 1st. ed: Houston, 31-35, 2006.
2. Dalal S. Fatigue: M.D. Anderson's Guide to Palliative Care for Nurses, 1st: Houston, 71-73, 2006.
 

Other

1. Online Article.

  Dalal S. Palliative Care <http://health.usnews.com/articles/health/cancer/2008/06/03/palliative-care.html>. Accessed August 14, 2008.

.

Grant & Contract Support

Title: Association between body composition and docetaxel-induced toxicity in male prostate cancer patients receiving single agent docetaxel therapy
Funding Source: NIH/NCI
Role: Collaborator
Principal Investigator: Yeung, Sai-Ching J.
Duration: 3/6/2013 - present
 
Title: The effects of Dehydroepiandrosterone (DHEA) on cachexia symptom cluster in advanced cancer patients
Funding Source: NIH/NCI
Role: Principal Investigator
Duration: 9/1/2008 - 8/31/2010
 
Title: Relationship between immune, endocrine and body composition alterations in male and female patients with pancreatic cancer: Impact on clinical outcomes
Funding Source: Other
Role: Principal Investigator

Last updated: 12/6/2013